Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

(AVAGAST) A Double-blind, Randomised, Multicenter, Phase III Study of Bevacizumab in Combination With Capecitabine and Cisplatin Versus Placebo in Combination With Capecitabine and Cisplatin, as First-line Therapy in Patients With Advanced Gastric Cancer
bevacizumab
AVF4200G/BO20904
NCT00548548
gastric cancer
Phase 3
 
June 2017

Powered by ideaPoint, Inc.